Search

everythinglearnresearchcommunity

for

Search:↓

Merkel cell carcinoma is most likely to recur within two years of diagnosis, and factors like immune suppression, being over 75, and male sex increase this risk.

Alopecia areata patients show unique protein activity patterns, suggesting imbalanced signaling pathways.

Understanding the APCDD1 gene can lead to new hair loss treatments.

A keratin hHb6 mutation causes a hair disorder with varying severity, influenced by other factors.

Sebaceous glands are often preserved and PPARy expression is constant in some cases of Central Centrifugal Cicatricial Alopecia.

Researchers found genetic mutations causing hypohidrotic ectodermal dysplasia in 88% of studied patients and identified new mutations and genetic variations affecting the disease.

Nonclassic congenital adrenal hyperplasia is a common genetic disorder that can cause a range of symptoms and requires personalized treatment.

NAG-1 may help prevent some metabolic issues related to PCOS.

New mouse models help study melanocytic cells for melanoma research.

Mitf plays a key role in melanoma progression and is linked to disease stage.

Higher Lnk protein levels in ovaries may lead to insulin resistance in women with PCOS.

Nevoid basal cell carcinomas start in the skin's top layer and hair follicles.

The lump on a woman's scalp was a rare, potentially cancerous tumor from the hair follicle, not a common cyst.

K10 may not prevent tumors as previously thought and might increase benign tumor risk.

Ribonucleotide excision repair is crucial to prevent skin cancer.

5α-reductase inhibitors can reduce prostate cancer risk but may increase high-grade tumors, needing more research.

Targeting cholesterol, fatty acids, fibrosis, and mast cells may help treat CCCA.

Gefitinib treatment led to unexpected hair growth in two lung cancer patients.

Keratins are crucial for hair strength, and mutations in certain keratin genes cause hair disorders.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

PRSS35 enzyme may help start skin tumors and could be a target for cancer treatment.

A rare skin cancer on a man's elbow was successfully treated with surgery, showing no recurrence after one year.

ETS2 is crucial in squamous cell carcinoma development and could be a therapeutic target.

The balance between cell renewal and differentiation controls the growth of cancerous cells in mouse skin.

TSC22D genes are key in metabolic diseases and cancer, offering potential as treatment targets.

Inhibiting mTORC2 can reduce DNA repair and increase cancer cell death, suggesting potential for targeted brain cancer treatments.

Genetic mutations that disrupt homocysteine breakdown lead to increased damage in mouse hair keratin.

Mutations in specific genes cause certain congenital defects in dogs, aiding in understanding similar human diseases.

Researchers found a new gene area linked to male-pattern baldness, which, along with another gene, significantly increases the risk of hair loss in men.

A specific genetic trait in tumor cells is linked to longer survival without disease in certain lymphoma patients.